Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Epitelijski rak jajčnikov, rak jajcevodov, primarni peritonealni serozni karcinom (PPSC) : priporočila za sistemsko zdravljenje
Authors:ID Škof, Erik (Author)
ID Cerar, Olga (Author)
Files:.pdf PDF - Presentation file, download (1,66 MB)
MD5: CF7C26D6ABA97E73F260289C1F9753A1
PID: 20.500.12556/dirros/946923f3-d6b6-46b3-88f4-2f2c9109db0a
 
Language:Slovenian
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Keywords:rak (medicina), jajčniki, kemoterapija, zdravljenje, smernice
Publication status:Published
Publication version:Version of Record
Year of publishing:2015
Number of pages:str. 17-21, 37
Numbering:Letn. 19, št. 1
PID:20.500.12556/DiRROS-8155 New window
UDC:618.11-006-08
ISSN on article:1408-1741
COBISS.SI-ID:2139259 New window
Copyright:by Authors
Publication date in DiRROS:19.03.2018
Views:6850
Downloads:1350
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:03.01.2018

Secondary language

Language:English
Title:Epithelial ovarian cancer, fallopian tube cancer, primary peritoneal serous cancer (PPSC) : systemic treatment recommendations
Abstract:Epithelial ovarian cancer is known to be one of the most sensitive to systemic treatment with chemotherapy. Objective response to treatment was achieved in more than 80% of patients. Therefore, chemotherapy treatment is a standard part of primary treatment after completed surgery (adjuvant treatment), If surgical treatment is not possible, patients begin treatment with preoperative (neoadjuvant) chemotherapy, which is followed by surgery. In primary systemic treatment, we have been using chemotherapy in combination with taxanes and platinum-based preparations. In systemic treatment of fallopian tube cancer, we also use – besides chemotherapy – bevacizumab, an inhibitor of the vascular endothelial growth factor (VEGF). Systemic treatment presents the principal treatment also in disease recurrence. The type of systemic treatment in disease recurrence depends on the time elapsed since the end of primary treatment until recurrence. In the last couple of years, we have been again witnessing the introduction of new medicines for treatment of patients with fallopian tube cancer. For this reason, the Institute of Oncology Ljubljana this year updated its guidelines for systemic treatment of epithelial ovarian cancer. In this paper, we present the current recommendations for systemic treatment of epithelial ovarian cancer in Slovenia. Epithelial ovarian cancer, fallopian tube cancer and primary peritoneal serous cancer (PPSC) have the same clinical course and the same systemic treatment, therefore they are all managed in the same manner.


Archive

niGradiv

Back